Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate in postoperative biliary atresia survivors with cholestasis
jRCTs031210066Completed
- Sponsor
- Chiba University Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bezafibrate in biliary atresia and cholestasis, sponsored by Chiba University Hospital. Primary endpoint: Change in alkaline phosphatase (ALP) from baseline to Week 12. Started May 2021; status: completed.
02
Drugs
bezafibrate
03
Conditions
biliary atresiacholestasis
Beyond the preview
Go deeper on jRCTs031210066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210066.